While the oncology community is large, Jazz focuses on smaller groups of people facing unique challenges and difficult odds, such as those living with small cell lung cancer (SCLC). In the U.S., approximately 13 percent of lung cancers are small cell and nearly 30,000 new cases of SCLC are recorded in the U.S. every year.1
Jazz creates a thoughtful development strategy for every molecule and treatment we pursue through our comprehensive research and development efforts. Critical to these efforts are our partnerships with leading patient advocacy organizations like LUNGevity. These partnerships allow us to gain important insights and work towards the common goal of supporting patients and their caregivers throughout their journey.
While our priority is to deliver novel therapies to cancer communities with unmet needs, we are equally dedicated to supporting people living with difficult-to-treat cancers and their loved ones, to ensure that they have access to educational, psychosocial and community support resources along their survivorship paths.
Jazz’s Anne Borgman, MD, Vice President and Head of Hematology-Oncology Clinical Development, met with Andrea Ferris, President and CEO of LUNGevity, a U.S. based lung cancer patient advocacy group, to have an informative discussion on the importance of research and development, partnerships and innovation to address the unmet needs of the SCLC community.
References
1American Cancer Society. Cancer Facts & Figures 2020. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2020/cancer-facts-and-figures-2020.pdf (accessed May 22, 2020).
الإبلاغ عن أثر جانبي
إذا كنت ترغب في الإبلاغ عن أثر جانبي مرتبط بالمنتجات الدوائية لشركة Jazz Pharmaceuticals، يُرجى إرسال بريد إلكتروني إلينا عبر الرابط التالي:
يُرجى تقديم أكبر قدر ممكن من المعلومات المتاحة.
تشمل المعلومات ذات الصلة ما يلي:
بتقديمك لتقريرك وتزويدنا ببيانات الاتصال الخاصة بك، فإنك تُقرّ وتوافق صراحةً على أنه يجوز لقسم السلامة الدوائية المحلي التواصل معك بغرض طلب معلومات إضافية أو توضيحات، إذا اعتُبر ذلك ضروريًا لتقييم التقرير ومتابعته.
يوضح إشعار الخصوصية الخاص بنا المتعلق باليقظة الدوائية والمعلومات الطبية وشكاوى المنتجات كيفية تعامل شركة Jazz Pharmaceuticals مع معالجة المعلومات الشخصية عند التعامل مع تقريرالأثر الجانبي الخاص بك، وهو متاح في مركز الخصوصية لدينا.
Report an Adverse Event
If you want to report a Adverse Event related to Jazz Pharmaceuticals medicinal products, then please send us an e-mail via this link:
Please provide as much available information as possible.
Relevant information includes:
By submitting your report and providing your contact details, you expressly acknowledge and agree that the local drug safety department may contact you for the purpose of requesting additional information or clarifications, should this be deemed necessary for the assessment and follow‑up of the report.
Our Privacy Notice for Pharmacovigilance, Medical Information and Product Complaints outlines how Jazz Pharmaceuticals handles the processing of personal information when dealing with your adverse event report and is available in our Privacy Center.
